Association of Weight Change, Inflammation Markers and Disease Staging with Survival of Patients Undergoing Chemotherapy for Pancreatic Adenocarcinoma
CONCLUSION: WL was an independent prognostic factor for survival. Particularly in early stage disease, interventions targeting this modifiable factor may translate into better outcomes for PA patients. NLR may be a surrogate marker of systemic inflammatory status in this setting.PMID:33749421 | DOI:10.1080/01635581.2021.1903049
Source: Nutrition and Cancer - Category: Cancer & Oncology Authors: Leonor Vasconcelos de Matos Andreia Coelho Renato Cunha Leonor Fernandes M ário Fontes E Sousa Maria Teresa Neves D ébora Cardoso Mariana Malheiro Joana Gra ça Eug énia Santos Silva Ana Pl ácido Ana Martins Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Nutrition | Pancreas | Pancreatic Cancer | Statistics | Study | Weight Loss